microangiopathy, particularly in the presence of diabetes, and with compressive lesions caused by intracranial aneurysms. They are a rare presenting sign in bilateral subdural haematoma. A review of 114 cases of bilateral subdural haematoma identified no cases in which the presentation involved an oculomotor nerve palsy.
1
Two cases have been published describing oculomotor nerve palsies in association with bilateral subdural haematoma. One describes a case similar to that reported here in which CT investigation of a patient presenting with an isolated oculomotor nerve palsy revealed bilateral chronic subdural haematoma, which also resolved following surgical evacuation. 2 The other describes a case of oculomotor nerve palsy and hemiparesis complicating the surgical drainage of subdural haematoma. 3 Subdural haematoma rarely affects the anterior visual pathways, more commonly affecting the posterior pathways in the form of homonymous hemianopia. However, this case involved in addition to the oculomotor nerve palsy, an ipsilateral reduction in visual acuity, which subsequently resolved upon drainage of the haematoma. Both signs may have arisen by the same mechanism. This patients CT brain revealed bilateral subdural haematoma causing downward displacement of the cerebral hemispheres with herniation of the uncal portion of the temporal lobe. This in turn is likely to have led to compression and paresis of the oculomotor nerve. The downward displacement may have led to traction of the optic nerve, which in this case, with a history of ischaemic optic neuropathy, is known to be vascularly compromised, resulting in reversible reduction in visual acuity. Following evacuation of the haematoma, with release of the traction on the optic nerve, normal visual acuity was restored. Hollander and Stewart 4 describe a similar case in which sudden painless visual loss occurred in the presence of subdural haematoma with partial resolution following drainage. They similarly speculate that midline shift caused by subdural haematoma led to optic nerve traction and vascular compromise that was not detectable on imaging.
The patient in this case also described formed visual hallucinations occurring upon closing his eyes. Manford and Andermann 5 describe three mechanisms by which complex visual hallucinations may occur: epileptic hallucinations due to direct irritation of cortical centres; visual pathway lesions resulting in defective visual processing with abnormal cortical release phenomena (Charles-Bonnet hallucinations) and disturbance of ascending cholinergic and serotonergic pathways in brainstem lesions. In this case the visual hallucinations described were most likely caused by direct stimulation of cortical centres by the presence of the subdural haematoma. Charles-Bonnet hallucinations are less likely, given the relatively short duration of this patients' visual loss and the fact that these hallucinations were present only upon closing his eyes.
In summary, this case represents an unusual presentation of bilateral subacute subdural haematoma with oculomotor palsy, visual loss, and hallucinations. Although adipose tissue comprises a large portion of the orbit, liposarcomas consisted of only 2% of primary orbital tumours, and were hardly ever included in the clinical differential diagnosis of orbital lesions. 1 We report a 24-year-old woman who suffered from recurrent orbital liposarcoma with unusual findings. She first presented with right 3 mm exophthalmos and limitation of eye movements that developed within 2 weeks. Her visual acuity was 6/6. CT scan and MRI revealed an extraconal lesion, consisting of fat, soft tissue, and calcifications at the roof of the right orbit, pushing down the superior rectus. The patient postponed surgery for 5 months and the proptosis progressed to 6 mm. She underwent anterior and lateral orbitotomy with incomplete debulking of the tumour found between the levator and the superior rectus muscles. After surgery, she felt well for 8 months, when proptosis recurred (Figure 1a ) with complete limitation of upward gaze. The visual acuity was 6/6. CT and MRI revealed a heterogenic tissue filling the right upper orbit (Figure 1b) . Another operation was performed 16 months after the first one and the tumour was excised through a lid-crease incision, using a cryo-probe. At follow-up 1.5 years later, ptosis and hypoglobus persisted, but with no signs of tumour recurrence.
Paraffin sections from the primary tumour revealed a lipoma-like well-differentiated liposarcoma (WDL) composed of adipose lobules of mature adipocytes with variations in cell size and occasional cells with hyperchromatic nuclei, and scattered bizarre, multinucleated cells. Scattered lipoblasts were identified within fibrotic septa. A focus of metaplastic bone was present (Figure 1c ). The relapsing lesion was an inflammatory WDL with lipoma-like and sclerosing areas. It contained a prominent chronic inflammatory component with the formation of reactive lymphoid follicles (Figure 1d ). The lipomatous component contained adipocytes varying in size, with focally hyperchromatic nuclei and scattered multivacuolar cells. The sclerosing component was paucicellular with spindle fibroblastic cells and occasional atypical cells with hyperchromatic nuclei. Immunohistochemical examination showed that the lipocytes, some of the lipoblast-like cells and some of the spindle cells were positive for S-100 protein and negative for alpha smooth muscle actin, desmin, and CD68. Immunostaining for CD3, CD20, CD68, and CD138 demonstrated a reactive immunoarchitecture of the lymphoid component.
Comparative genomic hybridization (CGH) analysis that was performed, as far as we are aware, for the first time for an orbital liposarcoma, detected same chromosomal aberrations in both the primary and relapsing tumors. Changes in the DNA sequence copy number were:
and ÀXq. All aberrations were of a low level.
Discussion
While rare, the prognosis of orbital liposarcomas is not known. WDL outside the retroperitoneum is usually cured by wide resection with a 20-30% risk of local recurrence and up to 5% risk of dedifferentiation and metastasis. 2, 3 CGH might help indicate more malignant phenotypes. [4] [5] [6] While gains within chromosomes 1,4,5,6,8, 12, and 13 were found in WDL, gains within chromosomes 2 have not been reported before. Loss of chromosomal material, such as the loss of Xq found in our case, is generally detected less frequently in sarcomas than gains. 4 It was suggested that an increased number of aberrations, over-representations of chromosomal subregion 12q24, and amplification of 1q may indicate a more malignant phenotype. 4, 6 The commonly accepted classification of liposarcoma by the World Health Organization 7 distinguishes between well-differentiated, myxoid, round cell, pleomorphic, and dedifferentiated groups. WDL is further classified into lipoma-like, sclerosing, and inflammatory subgroups. 3, 7 Unusually, metaplasia into cartilaginous, osseous, and smooth muscle elements may present in liposarcoma. 8 However, metaplastic bone in orbital liposarcoma, to the best of our knowledge, has not been previously described. Inflammatory WDL is rare and almost always retroperitoneal. Inflammatory WDL, as found in the recurrent lesion of our patient, has been described only once as an orbital primary tumour 3 and has not been previously reported as a recurrent orbital liposarcoma.
A recent classification from The Armed Forces Institute of Pathology 8 groups together the WDL, atypical lipoma, and pleomorphic lipoma into one category of 'atypical lipomatous tumor' located between the benign and malignant groups, as it contains cells with irregular, hyperchromatic nuclei but does not metastasize. It was also argued that the differentiation between lipoma-like, sclerosing, and inflammatory subgroups have no significance and may occur in the same tumour. Our finding of the same chromosomal imbalances in the primary lipoma-like tumour and in the inflammatory relapsing tumour also suggests that these subtypes should be grouped together.
In summary, liposarcoma with metaplastic bone and recurrent liposarcoma with inflammatory component should be added to the differential diagnosis of rare orbital lesions. A 49-year-old woman presented to eye casualty with blurred vision and pain in both eyes. She had been diagnosed with irritable bowel syndrome (IBS) 4 years earlier and her gastroenterologist had prescribed venlafaxine earlier that day. At 4 h after taking the first oral dose, she developed symptoms of pain and blurred vision simultaneously in both eyes. She also reported nausea and vomiting.
On examination, visual acuities were 6/18 in the right eye and 6/12 in the left. Both pupils were fixed and mid-dilated. There was bilateral corneal oedema and shallow anterior chambers were evident. Gonioscopy revealed angle closure in both eyes. Intraocular pressures (IOPs) were 49 mmHg in the right eye and 54 mmHg in the left. A diagnosis of bilateral acute angle closure glaucoma was made.
